Danielle Hicks

“The good news in spite of all of this and even since the pandemic is that things are happening fast and furiously in the lung cancer space, so whether its new drug developments, new technologies for diagnostics, you name it – these things are happening and like I said it’s unfair to expect that a physician treating all these cancer types is going to be up to speed.”

- Lung Cancer Patients and COVID

“The hope here is that – maybe we’ll be able – the proof will be in the pudding, that we can expedite the clinical trial process in getting drugs from the lab to the patients in a clinical trial setting and then out into the general population.”

- Lung Cancer Patients and COVID

[On measures taken by cancer centers] "There's a couple of things both inside and outside of a medical facility that can be done - telehealth, of course, plays a big role for patients who don't necessarily need to come into the physician, but they need to connect with their physician or someone for their care team for one reason or another. Some of the work that we've done is community advocacy to federal and state leaders during the time of the pandemic, to identify and communicate the needs of our community around issues such as expanding telehealth, testing medical supplies, fairness, and access to treatments and medications."

- Lung Cancer Patients and COVID

"Another thing that's, been an interesting sort of shift and is done where applicable is changes in dosing regimens. The amount of time in between a physician's visit can be extended - immunotherapy in a good example of where they're changing the length of time that you're required to have your treatment."

- Lung Cancer Patients and COVID